Filing Details
- Accession Number:
- 0001209191-18-003008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-09 18:00:15
- Reporting Period:
- 2018-01-05
- Accepted Time:
- 2018-01-09 18:00:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 897448 | Amarin Corp Plc | AMRN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1289884 | B Steven Ketchum | C/O Amarin Pharma, Inc. 1430 Route 206 Bedminster NJ 07921 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2018-01-05 | 64,683 | $2.04 | 206,480 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2018-01-05 | 64,683 | $4.40 | 141,797 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (right to buy) | Disposition | 2018-01-05 | 64,683 | $0.00 | 64,683 | $2.04 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 137,817 | 2024-01-08 | No | 4 | M | Direct |
Footnotes
- The exercise and sale transaction reported in the Form 4 is made pursuant to a Rule 10b5-1 plan.
- The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.40 to $4.41, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Ordinary Shares sold at each separate price.
- Please see the section titled "Remarks" below for additional information.
- On January 8, 2014, the Reporting Person was granted an option to purchase 202,500 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan. The shares subject to this option are fully vested and exercisable as of the date of this Form 4.
Billionaire Hedge Funds
